Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.3M Sell
62,540
-33,218
-35% -$1.22M 5.61% 4
2020
Q3
$3.33M Sell
95,758
-41,479
-30% -$1.45M 5.45% 5
2020
Q2
$4.26M Sell
137,237
-167,617
-55% -$5.69M 4.51% 3
2020
Q1
$9.44M Buy
304,854
+87,849
+40% +$2.99M 7.48% 1
2019
Q4
$8.07M Sell
217,005
-177,457
-45% -$6.32M 1.91% 20
2019
Q3
$13.4M Sell
394,462
-383,198
-49% -$13.9M 2.3% 15
2019
Q2
$32M Sell
777,660
-200,736
-21% -$7.97M 2.68% 9
2019
Q1
$39.4M Buy
978,396
+544,502
+125% +$21.8M 4.93% 6
2018
Q4
$17.8M Buy
+433,894
New +$18M 1.98% 15

Other funds holding PFE

H2O AM's PFE Position: Q4 2020 in Review

H2O AM reduced its Pfizer (PFE) stake by 35% in Q4 2020, selling an estimated $1.22M and leaving 62,540 shares worth $2.3M. The position accounts for 5.61% of the portfolio, ranked #4.

H2O AM first reported a position in PFE in Q4 2018 and has held it in 9 quarters since. The position peaked at $39.4M in Q1 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • H2O AM held 62,540 shares of Pfizer worth $2.3M as of Q4 2020.
  • H2O AM sold 33,218 Pfizer shares in Q4 2020, an estimated $1.22M.
  • Pfizer made up 5.61% of H2O AM's portfolio in Q4 2020, its #4 holding.
  • H2O AM first reported a position in Pfizer in Q4 2018 and has held it in 9 quarters since.
  • H2O AM's Pfizer position peaked at $39.4M in Q1 2019.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on H2O AM's 13F filing for Q4 2020, filed 12 Feb 2021.